Scars, burns & healing最新文献

{"title":"Treatment of burn scars in Fitzpatrick phototype III patients with a combination of pulsed dye laser and non-ablative fractional resurfacing 1550 nm erbium:glass/1927 nm thulium laser devices.","authors":"Joy Tao, Amanda Champlain, Charles Weddington, Lauren Moy, Rebecca Tung","doi":"10.1177/2059513118758510","DOIUrl":"10.1177/2059513118758510","url":null,"abstract":"<p><strong>Introduction: </strong>Burn scars cause cosmetic disfigurement and psychosocial distress. We present two Fitzpatrick phototype (FP) III patients with burn scars successfully treated with combination pulsed dye laser (PDL) and non-ablative fractional lasers (NAFL).</p><p><strong>Case 1: </strong>A 30-year-old, FP III woman with a history of a second-degree burn injury to the bilateral arms and legs affecting 30% body surface area (BSA) presented for cosmetic treatment. The patient received three treatments with 595 nm PDL (7 mm, 8 J, 6 ms), six with the 1550 nm erbium:glass laser (30 mJ, 14% density, 4-8 passes) and five with the 1927 nm thulium laser (10 mJ, 30% density, 4-8 passes). Treated burn scars improved significantly in thickness, texture and colour.</p><p><strong>Case 2: </strong>A 33-year-old, FP III man with a history of a second-degree burn injury of the left neck and arm affecting 7% BSA presented for cosmetic treatment. The patient received two treatments with 595 nm PDL (5 mm, 7.5 J, 6 ms), four with the 1550 nm erbium:glass laser (30 mJ, 14% density, 4-8 passes) and two with the 1927 nm thulium laser (10 mJ, 30% density, 4-8 passes). The burn scars became thinner, smoother and more normal in pigmentation and appearance.</p><p><strong>Discussion: </strong>Our patients' burn scars were treated with a combination of PDL and NAFL (two wavelengths). The PDL targets scar hypervascularity, the 1550 nm erbium:glass stimulates collagen remodelling and the 1927 nm thulium targets epidermal processes, particularly hyperpigmentation. This combination addresses scar thickness, texture and colour with a low side effect profile and is particularly advantageous in patients at higher risk of post-procedure hyperpigmentation.</p><p><strong>Conclusion: </strong>Our cases suggest the combination of 595nm PDL plus NAFL 1550 nm erbium:glass/1927 nm thulium device is effective and well-tolerated for burn scar treatment in skin of colour.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"4 ","pages":"2059513118758510"},"PeriodicalIF":0.0,"publicationDate":"2018-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/fc/10.1177_2059513118758510.PMC5965338.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36129980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A RandomizEd trial of ENtERal Glutamine to minimIZE thermal injury (The RE-ENERGIZE Trial): a clinical trial protocol.","authors":"Daren K Heyland, Paul Wischmeyer, Marc G Jeschke, Lucy Wibbenmeyer, Alexis F Turgeon, Henry T Stelfox, Andrew G Day, Dominique Garrel","doi":"10.1177/2059513117745241","DOIUrl":"10.1177/2059513117745241","url":null,"abstract":"<p><strong>Background: </strong>Burn injury represents a significant public health problem worldwide. More than in any other injury, the inflammation and catabolism associated with severe burns can exacerbate nutrient deficiencies resulting in impaired immune function and increased risk of developing infection, organ dysfunction and death. Consequently, over the last few decades numerous trials have evaluated the impact of different nutritional strategies in severe burn injury. Glutamine is of particular interest, as it appears vital for a number of key stress-response pathways in serious illness. The purpose of the current manuscript is to provide the rationale and protocol for a large clinical trial of supplemental enteral glutamine in 2700 severe burn-injured patients.</p><p><strong>Methods: </strong>We propose a multicentre, double-blind, pragmatic, randomized, clinical trial involving 80 tertiary intensive care unit (ICU) burn centres worldwide. We aim to enrol patients with deep second- and/or third-degree burns at moderate or high risk for death. We will exclude patients admitted > 72 h before screening and patients with advanced liver and kidney disease. The study intervention consists of enteral glutamine 0.5 g/kg/day vs. isocaloric maltodextran control delivered enterally. Primary outcome will be six-month mortality. Key secondary outcomes include time to discharge alive from hospital, ICU and hospital mortality, length of stay and health-related quality of life at six months.</p><p><strong>Significance: </strong>This study will be the first large international multicentre trial examining the effects of glutamine in burn patients. Negative or positive, the results of this trial will inform the clinical practice of burns care worldwide.Clinicaltrials.gov ID #NCT00985205.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117745241"},"PeriodicalIF":0.0,"publicationDate":"2017-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/6c/10.1177_2059513117745241.PMC5965329.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36131232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Brachytherapy in the adjuvant management of keloid scars: literature review.","authors":"Ioannis Goutos, Rei Ogawa","doi":"10.1177/2059513117735483","DOIUrl":"10.1177/2059513117735483","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Radiation therapy is a well-recognised modality for the adjuvant treatment of keloid scars. It can be conventionally delivered as external beam using a large apparatus at a distance from the lesion or as brachytherapy with specialised equipment to enable the delivery of treatment in the immediate vicinity of the keloidal tissue.</p><p><strong>Methods: </strong>An English literature review was performed with keywords 'brachytherapy' and 'keloid' using the databases PubMed, Embase and Web of Science from their individual dates of inception until June 2017. Studies pertinent to the field are presented in a chronological manner to depict the evolution of different brachytherapy strategies over the last decades. We also discuss considerations relating to the risk of secondary carcinogenesis, which are relevant to shared decision-making in the clinical setting.</p><p><strong>Discussion: </strong>Low dose rate interstitial brachytherapy was first introduced in the English literature in 1976 and currently appears to have been superseded by more modern approaches, including high dose rate interstitial brachytherapy. This modality compares favourably to more traditional modes of radiotherapy in terms of recurrence as well as rates of symptomatic relief from keloidal symptoms. Superficial brachytherapy was introduced more recently in the relevant literature and appears to be associated with favourable therapeutic outcomes compared to external beam radiation therapy.</p><p><strong>Conclusion: </strong>Brachytherapy is a valid modality of radiotherapy for the adjuvant treatment of keloid scars, with high dose rate interstitial and surface regimens gaining in popularity over recent years. Further research needs to focus on randomised controlled trials to further establish the role of different radiotherapy modalities in keloid scar management.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117735483"},"PeriodicalIF":0.0,"publicationDate":"2017-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2059513117735483","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36129978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Autologous fat grafting for scars, healing and pain: a review.","authors":"Harjoat Riyat, Leila L Touil, Matthew Briggs, Kayvan Shokrollahi","doi":"10.1177/2059513117728200","DOIUrl":"10.1177/2059513117728200","url":null,"abstract":"<p><strong>Introduction: </strong>Current guidelines suggest a multimodal approach to treating scars but there is no gold standard for treatment; however, there is exciting therapeutic potential for the use of autologous fat grafting (AFG). Functional and aesthetic improvements have been reported, including pain relief and scar quality improvement.</p><p><strong>Aims: </strong>To explore the current evidence regarding the use of AFG in hypertrophic and painful scars.</p><p><strong>Methods: </strong>A systematic review of the literature was conducted using 11 MeSH terms in PubMed, Medline and EMBASE. English studies that used AFG to treat scars in human participants were included.</p><p><strong>Results: </strong>A total of 746 studies were found and 23 studies (from 2008 to 2016) were included: five studies were evidence level V; nine studies were evidence level IV; eight were evidence level III; and one study was evidence level II. A total of 1158 patients were assessed for improvement in scar characteristics including colour, thickness, volume, pain and restoration of function at affected sites, following treatment. Positive outcomes were noted for all parameters and a significant improvement in AFG's analgesic effect was recorded in 567 out of 966 patients, <i>P</i> < 0.05.</p><p><strong>Discussion: </strong>AFG is a minimally invasive and safe approach to treating scars, a promising alternative to surgical excision. The technique of blunt cannula insertion optimises the release of scar retraction, which contributes to the analgesic effect of this treatment method. The evidence supports current theories of mesenchymal stem cell's regenerative and anti-inflammatory properties responsible for scar healing. There are limited high quality studies to support its use and future randomised controlled trials should be conducted.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117728200"},"PeriodicalIF":0.0,"publicationDate":"2017-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/b5/10.1177_2059513117728200.PMC5965331.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36131229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Burns from ignited household aerosols in the kitchen: a case series.","authors":"Anant Dinesh, Thais Polanco, Ryan Engdahl","doi":"10.1177/2059513117728202","DOIUrl":"10.1177/2059513117728202","url":null,"abstract":"<p><p>Aerosol sprays are commonly used products in daily living. Aerosols in kitchen products have prompted for use of 'food grade' or chemically inert propellants; however, they commonly contain gases or gaseous mixtures such as butane, propane and dimethyl ether that are flammable. When such sprays are used near heat sources, such as kitchen appliances, combustibles in these products can result in ignition and burn injury. Given the ubiquity of such sprays, surprisingly burns sustained from household aerosols are not characterised in the literature. We conducted a retrospective search of all burn patients treated at our hospital which contains a burn unit. Three patients were identified with burn wounds due to household aerosol sprays. All three occurred in the kitchen. and were characterized as first-degree and second-degree burns over the head and neck or upper extremities with one requiring inpatient admission. Where it may be perceived a cause of minor injury, household aerosol burns may result in significant burn injury and hospital admission. Household aerosols and burn injury are reviewed.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117728202"},"PeriodicalIF":0.0,"publicationDate":"2017-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/2b/10.1177_2059513117728202.PMC5965334.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36130585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Measuring coagulation in burns: an evidence-based systematic review.","authors":"Nicholas J Marsden, Martin Van, Samera Dean, Ernest A Azzopardi, Sarah Hemington-Gorse, Phillip A Evans, Iain S Whitaker","doi":"10.1177/2059513117728201","DOIUrl":"10.1177/2059513117728201","url":null,"abstract":"<p><strong>Introduction: </strong>Dynamic monitoring of coagulation is important to predict both haemorrhagic and thrombotic complications and to guide blood product administration. Reducing blood loss and tailoring blood product administration may improve patient outcome and reduce mortality associated with transfusion. The current literature lacks a systematic, critical appraisal of current best evidence on which clinical decisions may be based.</p><p><strong>Objectives: </strong>Establishing the role of different coagulation markers in burn patients, diagnosing coagulopathy, tailoring blood product administration and indicating prognosis.</p><p><strong>Methods: </strong>Literature during 2004-2017 from the Cochrane Library, PubMed, Scopus, Medline and Embase was reviewed. Eligibility criteria included randomised controlled trials, systematic reviews, multi-/single-centre study and meta-analyses. Keywords searched were 'burns', 'blood coagulation disorders', 'rotem', 'blood coagulation' and 'thromboelastography'. The PRISMA flow system was used for stratification and the CASP framework for appraisal of the studies retrieved.</p><p><strong>Results: </strong>In total, 13 articles were included after inclusion/exclusion criteria had been applied to the initial 79 studies retrieved. Hypercoagulation increases in proportion to the severity of thermal injury. Whole blood testing, using thrombelastography (TEG) and rotation thromboelastometry (ROTEM), was superior to standard plasma based tests, including prothrombin time (PT) and activated partial thromboplastin time (APTT) at detecting burn-related coagulopathies.</p><p><strong>Conclusions: </strong>Routine laboratory markers such as PT/APTT are poor indicators of coagulation status in burns patients. Viscoelastic tests, such as TEG and ROTEM, are efficient, fast and have a potential use in the management of burn patients; however, strong evidence is lacking. This review highlights the need for more randomised controlled trials, to guide future practice.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117728201"},"PeriodicalIF":0.0,"publicationDate":"2017-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/4a/10.1177_2059513117728201.PMC5965330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36130734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perspectives on acid attacks in the UK.","authors":"Kayvan Shokrollahi","doi":"10.1177/2059513117723769","DOIUrl":"10.1177/2059513117723769","url":null,"abstract":"","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117723769"},"PeriodicalIF":0.0,"publicationDate":"2017-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/68/10.1177_2059513117723769.PMC5965305.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36131129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A survivor's perspective of acid attacks in the UK: an open letter from Katie Piper.","authors":"Katie E Piper","doi":"10.1177/2059513117723768","DOIUrl":"10.1177/2059513117723768","url":null,"abstract":"","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117723768"},"PeriodicalIF":0.0,"publicationDate":"2017-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/71/10.1177_2059513117723768.PMC5965315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36131122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"TGF-β1 -509C/T polymorphism and susceptibility to keloid disease: a systematic review and meta-analysis.","authors":"Yiji Tu, William Charles Lineaweaver, Feng Zhang","doi":"10.1177/2059513117709943","DOIUrl":"10.1177/2059513117709943","url":null,"abstract":"<p><strong>Background: </strong>Keloid disease (KD) is common and often refractory to treatment. Definition of the genetic mechanisms of KD can lead to a better understanding of the disease and suggest more effective treatment strategies.</p><p><strong>Objectives: </strong>To quantitatively estimate the association between KD susceptibility and the -509C/T polymorphism in the TGF-β1 gene.</p><p><strong>Methods: </strong>PubMed, Embase and CNKI databases were searched using a combination of the Medical Subject Headings (MeSH) and relevant words in titles. Analyses were performed with STATA 12.0.</p><p><strong>Results: </strong>Five case-control studies encompassing a total of 564 keloid cases and 620 healthy controls were pooled in the final meta-analysis. Among the five studies, no significant association was detected between the TGF-β1 -509C/T polymorphism and KD under all of the five genetic models (allele comparison, heterozygote comparison, homozygote comparison, dominant model and recessive model) for the overall analyses and for the subgroup analyses based on DNA extraction method, participant ethnicity and group size. When stratified by study quality, three high-quality studies showed significant association under allele comparison and homozygote model (C versus T: OR = 0.80, 95% confidence interval [CI] = 0.65-0.98, <i>P</i> = 0.03; I² = 0%, <i>P</i> = 0.64; CC versus TT: OR = 0.62, 95% CI = 0.41-0.94, <i>P</i> = 0.02; I² = 0%, <i>P</i> = 0.79); while two moderate-quality studies showed significant association under allele comparison, homozygote model and recessive model (C versus T: OR = 1.52, 95% CI = 1.15-2.01, <i>P</i> = 0.004; I² = 39%, <i>P</i> = 0.20; CC versus TT: OR = 2.14, 95% CI = 1.24-3.70, <i>P</i> = 0.02; I² = 19%, <i>P</i> = 0.27; CC versus CT+TT: OR = 2.04, 95% CI = 1.29-3.24, <i>P</i> = 0.002; I² = 0%, <i>P</i> = 0.35).</p><p><strong>Conclusions: </strong>The current meta-analysis suggests that the TGF-β1 -509C/T polymorphism is not associated with KD susceptibility. High-quality and large-scale studies are needed to validate our findings.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117709943"},"PeriodicalIF":0.0,"publicationDate":"2017-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/65/10.1177_2059513117709943.PMC5965324.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36130578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medical and biological factors affecting mortality in elderly residential fire victims: a narrative review of the literature.","authors":"Erik Eggert, Fredrik Huss","doi":"10.1177/2059513117707686","DOIUrl":"10.1177/2059513117707686","url":null,"abstract":"<p><p>For older people (aged over 65 years), the risk of dying in a residential fire is doubled compared to the general population. Obvious causes of death mainly include smoke inhalation and burn injuries. That older people are more fragile and have more concurrent diseases is inherent, but what is it that makes them more vulnerable? It is known that the number of elderly people is increasing globally and that the increased risk of death in fires can be explained, at least in part, by physical and/or cognitive disabilities as well as socioeconomic and behavioural factors. The possibility that medical illnesses and an aging organism/tissues might explain this increased risk has not been shown to the same extent. Therefore, this narrative literature review focuses on medical and biological explanations. An initial search using the terms 'elderly', 'fatal', 'residential' and 'fire' yielded some interesting articles. Using a broader snowball search also accepting grey literature, several additional risk factors could be identified. Cardiovascular diseases, in particular atherosclerotic heart disease, greatly increases the vulnerability to, for example, carbon monoxide and probably also other asphyxiating gases. Cardiovascular diseases and lack of physical fitness may also increase vulnerability to heat. Burned elderly patients are also at a higher risk of death than younger patients, but it is controversial whether it is age itself or the pre-existing illnesses that come with age that increase the risk. Immunosenescence, malnutrition and female gender are other risk factors for poorer outcome after burns, all of which are common among older people.</p>","PeriodicalId":21495,"journal":{"name":"Scars, burns & healing","volume":"3 ","pages":"2059513117707686"},"PeriodicalIF":0.0,"publicationDate":"2017-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/be/10.1177_2059513117707686.PMC5965309.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36131231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}